Peter Stralfors
Overview
Explore the profile of Peter Stralfors including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
3077
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Nyman E, Cedersund G, Stralfors P
Trends Endocrinol Metab
. 2012 Jan;
23(3):107-15.
PMID: 22285743
Signaling pathways that only a few years ago appeared simple and understandable, albeit far from complete, have evolved into very complex multi-layered networks of cellular control mechanisms, which in turn...
22.
Nyman E, Fagerholm S, Jullesson D, Stralfors P, Cedersund G
FEBS J
. 2012 Jan;
279(6):987-99.
PMID: 22248283
Insulin signaling through insulin receptor (IR) and insulin receptor substrate-1 (IRS1) is important for insulin control of target cells. We have previously demonstrated a rapid and simultaneous overshoot behavior in...
23.
Nyman E, Brannmark C, Palmer R, Brugard J, Nystrom F, Stralfors P, et al.
J Biol Chem
. 2011 May;
286(29):26028-41.
PMID: 21572040
Type 2 diabetes is a metabolic disease that profoundly affects energy homeostasis. The disease involves failure at several levels and subsystems and is characterized by insulin resistance in target cells...
24.
Back K, Brannmark C, Stralfors P, Arnqvist H
Mol Cell Endocrinol
. 2011 Apr;
339(1-2):130-5.
PMID: 21524684
We compared insulin and IGF effects in adipocytes expressing IR (insulin receptors), and preadipocytes expressing IR and IGF-IR (IGF-I receptors). Treatment of adipocytes with insulin, IGF-II or IGF-I resulted in...
25.
Jufvas A, Stralfors P, Vener A
PLoS One
. 2011 Jan;
6(1):e15960.
PMID: 21249133
Epigenetic changes related to human disease cannot be fully addressed by studies of cells from cultures or from other mammals. We isolated human fat cells from subcutaneous abdominal fat tissue...
26.
Brannmark C, Palmer R, Glad S, Cedersund G, Stralfors P
J Biol Chem
. 2010 Apr;
285(26):20171-9.
PMID: 20421297
Insulin and other hormones control target cells through a network of signal-mediating molecules. Such networks are extremely complex due to multiple feedback loops in combination with redundancy, shared signal mediators,...
27.
Ost A, Svensson K, Ruishalme I, Brannmark C, Franck N, Krook H, et al.
Mol Med
. 2010 Apr;
16(7-8):235-46.
PMID: 20386866
Type 2 diabetes (T2D) is strongly linked to obesity and an adipose tissue unresponsive to insulin. The insulin resistance is due to defective insulin signaling, but details remain largely unknown....
28.
Asif M, Ali S, Nur O, Willander M, Brannmark C, Stralfors P, et al.
Biosens Bioelectron
. 2010 Mar;
25(10):2205-11.
PMID: 20303253
In this article, we report a functionalised ZnO-nanorod-based selective electrochemical sensor for intracellular glucose. To adjust the sensor for intracellular glucose measurements, we grew hexagonal ZnO nanorods on the tip...
29.
Ahmad F, Lindh R, Tang Y, Ruishalme I, Ost A, Sahachartsiri B, et al.
Biochem J
. 2009 Sep;
424(3):399-410.
PMID: 19747167
In adipocytes, PDE3B (phosphodiesterase 3B) is an important regulatory effector in signalling pathways controlled by insulin and cAMP-increasing hormones. Stimulation of 3T3-L1 adipocytes with insulin or the beta3-adrenergic receptor agonist...
30.
Danielsson A, Fagerholm S, Ost A, Franck N, Kjolhede P, Nystrom F, et al.
Mol Med
. 2009 Jul;
15(7-8):228-34.
PMID: 19593406
Insulin resistance and type 2 diabetes (T2D) are closely linked to obesity. Numerous prospective studies have reported on weight gain, insulin resistance, and insulin signaling in experimental animals, but not...